Susan L Bellis Selected Research

Sialyltransferases

1/2022	The incorrect use of CD75 as a synonym for ST6GAL1 has fostered the expansion of commercial "ST6GAL1" antibodies that do not recognize ST6GAL1.
1/2022	Sialyltransferase ST6GAL-1 mediates resistance to chemoradiation in rectal cancer.
1/2021	Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
10/2019	Sox2 promotes expression of the ST6Gal-I glycosyltransferase in ovarian cancer cells.
2/2018	Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.
1/2018	The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1α signaling.
1/2018	ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage.
1/2018	ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
1/2017	The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential.
4/2013	ST6Gal-I sialyltransferase confers cisplatin resistance in ovarian tumor cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan L Bellis Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 06/2005
5	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 10/2008
4	Colonic Neoplasms (Colon Cancer) 04/2013 - 06/2005
3	Wounds and Injuries (Trauma) 09/2017 - 09/2014
3	Carcinoma (Carcinomatosis) 04/2013 - 10/2008
2	Adenocarcinoma 01/2022 - 01/2018
2	Carcinogenesis 01/2018 - 01/2016
2	Neoplasm Metastasis (Metastasis) 12/2012 - 10/2008
2	Osteosarcoma (Osteogenic Sarcoma) 12/2008 - 02/2004
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 10/2020
1	Hypoxia (Hypoxemia) 01/2018
1	Diabetic Foot 09/2017
1	Ulcer 09/2017
1	Burns 09/2017
1	Infections 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 12/2013
1	Thrombosis (Thrombus) 05/2011
1	Inflammation (Inflammations) 10/2008

Drug/Important Bio-Agent (IBA)

11	SialyltransferasesIBA 01/2022 - 07/2011
9	GlycosyltransferasesIBA 01/2021 - 06/2005
8	IntegrinsIBA 01/2022 - 02/2004
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
6	Sialic AcidsIBA 01/2021 - 10/2008
5	EnzymesIBA 01/2021 - 10/2008
4	Polysaccharides (Glycans)IBA 01/2022 - 10/2008
4	Glycoproteins (Glycoprotein)IBA 01/2021 - 10/2008
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2018 - 01/2017
3	salicylhydroxamic acid (SHAM)IBA 09/2017 - 09/2014
3	Small Interfering RNA (siRNA)IBA 12/2013 - 10/2008
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2022 - 06/2005
2	AntibodiesIBA 01/2022 - 04/2013
2	Gemcitabine FDA Link 01/2018 - 01/2016
2	Death Domain ReceptorsIBA 01/2018 - 07/2011
2	CollagenIBA 09/2017 - 12/2008
2	Durapatite (Hydroxylapatite)IBA 12/2008 - 02/2004
2	Integrin beta1IBA 08/2008 - 06/2005
1	beta-D-Galactoside alpha 2-6-SialyltransferaseIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	AntralIBA 10/2020
1	PhosphotyrosineIBA 02/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2018
1	Cell Surface ReceptorsIBA 02/2018
1	Gefitinib (Iressa)FDA Link 02/2018
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2018
1	JNK Mitogen-Activated Protein KinasesIBA 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2018
1	oxalylglycineIBA 01/2018
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 09/2017
1	Hyaluronic Acid (Hyaluronan)IBA 09/2017
1	Proteoglycans (Proteoglycan)IBA 09/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2017
1	CytokinesIBA 09/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	VaccinesIBA 01/2016
1	silmitasertibIBA 12/2013
1	Casein Kinase II (Casein Kinase 2)IBA 12/2013
1	Cisplatin (Platino)FDA LinkGeneric 04/2013
1	Caspase 3 (Caspase-3)IBA 04/2013
1	PlatinumIBA 04/2013
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2013
1	Glycoside Hydrolases (Endoglycosidases)IBA 12/2012
1	CaspasesIBA 07/2011
1	Phenobarbital (Luminal)FDA Link 05/2011
1	Biocompatible Materials (Biomaterials)IBA 12/2008
1	Bovine Serum AlbuminIBA 12/2008
1	Fibronectins (Fibronectin)IBA 12/2008
1	LigandsIBA 08/2008
1	Galectin 3 (LGALS3)IBA 08/2008
1	LectinsIBA 08/2008
1	adhesion receptorIBA 06/2005
1	Blocking AntibodiesIBA 02/2004

Therapy/Procedure

1	Aftercare (After-Treatment) 01/2022
1	Chemoradiotherapy 01/2022
1	Therapeutics 02/2018
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2011